Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 192

1.

Retraction: Effects of hypoxia on monocyte inflammatory mediator production: Dissociation between changes in cyclooxygenase-2 expression and eicosanoid synthesis.

Demasi M, Cleland LG, Cook-Johnson RJ, Caughey GE, James MJ.

J Biol Chem. 2018 Dec 28;293(52):20013. doi: 10.1074/jbc.RX118.007017. Epub 2018 Dec 28. No abstract available.

2.

Disease activity trajectories in early rheumatoid arthritis following intensive DMARD therapy over 3 years: association with persistence to therapy.

Wabe N, Wojciechowski J, Wechalekar MD, Cleland LG, McWilliams L, Lee A, Proudman S, Wiese MD.

Int J Rheum Dis. 2017 Oct;20(10):1447-1456. doi: 10.1111/1756-185X.13184. Epub 2017 Sep 26.

PMID:
28952204
3.

Effects of hypoxia on monocyte inflammatory mediator production: Dissociation between changes in cyclooxygenase-2 expression and eicosanoid synthesis.

Demasi M, Cleland LG, Cook-Johnson RJ, Caughey GE, James MJ.

J Biol Chem. 2017 Sep 22;292(38):15993. doi: 10.1074/jbc.A117.305944. No abstract available.

4.

Effect of Adherence to Protocolized Targeted Intensifications of Disease-modifying Antirheumatic Drugs on Treatment Outcomes in Rheumatoid Arthritis: Results from an Australian Early Arthritis Cohort.

Wabe NT, Sorich MJ, Wechalekar MD, Cleland LG, McWilliams L, Lee AT, Spargo LD, Metcalf RG, Hall C, Proudman SM, Wiese MD.

J Rheumatol. 2016 Sep;43(9):1643-9. doi: 10.3899/jrheum.151392. Epub 2016 Jul 15.

PMID:
27422892
5.

The PTPN22 gene is associated with idiopathic inflammatory myopathy.

Maundrell A, Lester S, Rischmueller M, Hill C, Cleland LG, Blumbergs P, Wiese M, Limaye V.

Muscle Nerve. 2017 Feb;55(2):270-273. doi: 10.1002/mus.25222. Epub 2016 Nov 10.

PMID:
27312665
6.

Specialised pro-resolving mediators of inflammation in inflammatory arthritis.

Barden AE, Moghaddami M, Mas E, Phillips M, Cleland LG, Mori TA.

Prostaglandins Leukot Essent Fatty Acids. 2016 Apr;107:24-9. doi: 10.1016/j.plefa.2016.03.004. Epub 2016 Mar 9.

PMID:
27033423
7.

Drug-induced toxicity and patient reported outcomes in rheumatoid arthritis patients following intensive treated-to-target strategy: does ceasing therapy due to toxicity worsen outcomes in long term?

Wabe N, Sorich MJ, Wechalekar MD, Cleland LG, McWilliams L, Lee A, Hall C, Spargo L, Metcalf R, Proudman SM, Wiese MD.

Int J Clin Pract. 2016 Apr;70(4):340-50. doi: 10.1111/ijcp.12785. Epub 2016 Mar 14.

PMID:
26987888
8.

Ten years of publicly funded biological disease-modifying antirheumatic drugs in Australia.

Hopkins AM, Proudman SM, Vitry AI, Sorich MJ, Cleland LG, Wiese MD.

Med J Aust. 2016 Feb 1;204(2):64-8.

PMID:
26821102
9.

Supplementation with omega-3 fish oil has no effect on bone mineral density in adults with knee osteoarthritis: a 2-year randomized controlled trial.

Chen JS, Hill CL, Lester S, Ruediger CD, Battersby R, Jones G, Cleland LG, March LM.

Osteoporos Int. 2016 May;27(5):1897-905. doi: 10.1007/s00198-015-3438-x. Epub 2015 Dec 22.

PMID:
26694596
10.

Determining the acceptable level of physician compliance with a treat-to-target strategy in early rheumatoid arthritis.

Wabe N, Sorich MJ, Wechalekar MD, Cleland LG, McWilliams L, Lee A, Spargo L, Metcalf R, Hall C, Proudman SM, Wiese MD.

Int J Rheum Dis. 2017 May;20(5):576-583. doi: 10.1111/1756-185X.12816. Epub 2015 Dec 22.

PMID:
26692459
11.

Fish oil in knee osteoarthritis: a randomised clinical trial of low dose versus high dose.

Hill CL, March LM, Aitken D, Lester SE, Battersby R, Hynes K, Fedorova T, Proudman SM, James M, Cleland LG, Jones G.

Ann Rheum Dis. 2016 Jan;75(1):23-9. doi: 10.1136/annrheumdis-2014-207169. Epub 2015 Sep 9.

PMID:
26353789
12.

Plasma n-3 fatty acids and clinical outcomes in recent-onset rheumatoid arthritis.

Proudman SM, Cleland LG, Metcalf RG, Sullivan TR, Spargo LD, James MJ.

Br J Nutr. 2015 Sep 28;114(6):885-90. doi: 10.1017/S0007114515002718. Epub 2015 Aug 18.

PMID:
26283657
13.

Characterising deviation from treat-to-target strategies for early rheumatoid arthritis: the first three years.

Wabe N, Sorich MJ, Wechalekar MD, Cleland LG, McWilliams L, Lee A, Spargo L, Metcalf RG, Hall C, Proudman SM, Wiese MD.

Arthritis Res Ther. 2015 Mar 8;17:48. doi: 10.1186/s13075-015-0562-0.

14.

Synovial fluid and plasma n3 long chain polyunsaturated fatty acids in patients with inflammatory arthritis.

Moghaddami M, James M, Proudman S, Cleland LG.

Prostaglandins Leukot Essent Fatty Acids. 2015 Jun;97:7-12. doi: 10.1016/j.plefa.2015.02.005. Epub 2015 Mar 16.

PMID:
25817850
15.

Synovial fluid myeloid dendritic cells display important differences compared to monocyte-derived dendritic cells prepared in vitro.

Moghaddami M, James M, Whittle SL, Cleland LG.

Clin Transl Immunology. 2014 Aug 8;3(8):e23. doi: 10.1038/cti.2014.19. eCollection 2014 Aug.

16.

Multicentric myofibroblastic sarcoma.

Wechalekar MD, Ayres O, Farshid G, Clayer M, Cleland LG.

BMJ Case Rep. 2014 Nov 3;2014. pii: bcr2013201666. doi: 10.1136/bcr-2013-201666.

17.

Appendicular skeletal muscle in hospitalised hip-fracture patients: development and cross-validation of anthropometric prediction equations against dual-energy X-ray absorptiometry.

Villani AM, Crotty M, Cameron ID, Kurrle SE, Skuza PP, Cleland LG, Cobiac L, Miller MD.

Age Ageing. 2014 Nov;43(6):857-62. doi: 10.1093/ageing/afu106. Epub 2014 Jul 21.

PMID:
25049262
18.

The rheumatoid arthritis susceptibility polymorphism PTPN22 C1858T is not associated with leflunomide response or toxicity.

Hopkins AM, O'Doherty CE, Foster DJ, Suppiah V, Upton RN, Spargo LD, Cleland LG, Proudman SM, Wiese MD.

J Clin Pharm Ther. 2014 Oct;39(5):555-60. doi: 10.1111/jcpt.12189. Epub 2014 Jul 8.

PMID:
25040563
19.

Pitfalls in the use of randomised controlled trials for fish oil studies with cardiac patients.

James MJ, Sullivan TR, Metcalf RG, Cleland LG.

Br J Nutr. 2014 Sep 14;112(5):812-20. doi: 10.1017/S0007114514001408. Epub 2014 Jun 16.

PMID:
24933212
20.

RE: Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.

Cleland LG, Proudman SM, James MJ.

J Natl Cancer Inst. 2014 Apr;106(4):dju022. doi: 10.1093/jnci/dju022. Epub 2014 Mar 31. No abstract available.

PMID:
24685932
21.

Pharmacogenomics of NAT2 and ABCG2 influence the toxicity and efficacy of sulphasalazine containing DMARD regimens in early rheumatoid arthritis.

Wiese MD, Alotaibi N, O'Doherty C, Sorich MJ, Suppiah V, Cleland LG, Proudman SM.

Pharmacogenomics J. 2014 Aug;14(4):350-5. doi: 10.1038/tpj.2013.45. Epub 2014 Jan 7.

PMID:
24394199
22.

Gemcitabine-induced radiation recall myositis in a patient with dermatomyositis.

Graf SW, Limaye VS, Cleland LG.

Int J Rheum Dis. 2014 Jul;17(6):696-7. doi: 10.1111/1756-185X.12233. Epub 2013 Nov 28. No abstract available.

PMID:
24283707
23.

U-shaped relationship between tissue docosahexaenoic acid and atrial fibrillation following cardiac surgery.

Metcalf RG, Skuladottir GV, Indridason OS, Sullivan TR, Bjorgvinsdottir L, Sanders P, Arnar DO, Gibson RA, Heidarsdottir R, Cleland LG, Palsson R, Farquharson AL, Young GD, James MJ.

Eur J Clin Nutr. 2014 Jan;68(1):114-8. doi: 10.1038/ejcn.2013.215. Epub 2013 Oct 30.

PMID:
24169465
24.

Epidemiology of biopsy-proven giant cell arteritis in South Australia.

Dunstan E, Lester SL, Rischmueller M, Dodd T, Black R, Ahern M, Cleland LG, Roberts-Thomson P, Hill CL.

Intern Med J. 2014 Jan;44(1):32-9. doi: 10.1111/imj.12293.

PMID:
24118799
25.

Fish oil in recent onset rheumatoid arthritis: a randomised, double-blind controlled trial within algorithm-based drug use.

Proudman SM, James MJ, Spargo LD, Metcalf RG, Sullivan TR, Rischmueller M, Flabouris K, Wechalekar MD, Lee AT, Cleland LG.

Ann Rheum Dis. 2015 Jan;74(1):89-95. doi: 10.1136/annrheumdis-2013-204145. Epub 2013 Sep 30.

PMID:
24081439
26.

Molecular basis for differential elongation of omega-3 docosapentaenoic acid by the rat Elovl5 and Elovl2.

Gregory MK, Cleland LG, James MJ.

J Lipid Res. 2013 Oct;54(10):2851-7. doi: 10.1194/jlr.M041368. Epub 2013 Jul 21.

27.

Fish oil administration in older adults with cardiovascular disease or cardiovascular risk factors: is there potential for adverse events? A systematic review of the literature.

Villani AM, Crotty M, Cleland LG, James MJ, Fraser RJ, Cobiac L, Miller MD.

Int J Cardiol. 2013 Oct 9;168(4):4371-5. doi: 10.1016/j.ijcard.2013.05.054. Epub 2013 Jun 3. Review. No abstract available.

PMID:
23742929
28.

Prostaglandin D(2) in inflammatory arthritis and its relation with synovial fluid dendritic cells.

Moghaddami M, Ranieri E, James M, Fletcher J, Cleland LG.

Mediators Inflamm. 2013;2013:329494. doi: 10.1155/2013/329494. Epub 2013 May 7.

29.

Fish oil administration in older adults: is there potential for adverse events? A systematic review of the literature.

Villani AM, Crotty M, Cleland LG, James MJ, Fraser RJ, Cobiac L, Miller MD.

BMC Geriatr. 2013 May 1;13:41. doi: 10.1186/1471-2318-13-41. Review.

30.

Association of DHODH haplotype variants and response to leflunomide treatment in rheumatoid arthritis.

O'Doherty C, Schnabl M, Spargo L, Cleland LG, James M, Proudman SM, Wiese MD.

Pharmacogenomics. 2012 Sep;13(12):1427-34. doi: 10.2217/pgs.12.118.

PMID:
22966891
31.

Polymorphisms in cytochrome P450 2C19 enzyme and cessation of leflunomide in patients with rheumatoid arthritis.

Wiese MD, Schnabl M, O'Doherty C, Spargo LD, Sorich MJ, Cleland LG, Proudman SM.

Arthritis Res Ther. 2012 Jul 12;14(4):R163. doi: 10.1186/ar3911.

32.

Osteoarthritis. Omega-3 fatty acids and synovitis in osteoarthritic knees.

Cleland LG, James MJ.

Nat Rev Rheumatol. 2012 Apr 17;8(6):314-5. doi: 10.1038/nrrheum.2012.60. No abstract available.

PMID:
22508432
33.

Elongase reactions as control points in long-chain polyunsaturated fatty acid synthesis.

Gregory MK, Gibson RA, Cook-Johnson RJ, Cleland LG, James MJ.

PLoS One. 2011;6(12):e29662. doi: 10.1371/journal.pone.0029662. Epub 2011 Dec 22.

34.

Active foot synovitis in patients with rheumatoid arthritis: applying clinical criteria for disease activity and remission may result in underestimation of foot joint involvement.

Wechalekar MD, Lester S, Proudman SM, Cleland LG, Whittle SL, Rischmueller M, Hill CL.

Arthritis Rheum. 2012 May;64(5):1316-22. doi: 10.1002/art.33506.

35.

Effect of dietary fish oil on atrial fibrillation after cardiac surgery.

Farquharson AL, Metcalf RG, Sanders P, Stuklis R, Edwards JR, Gibson RA, Cleland LG, Sullivan TR, James MJ, Young GD.

Am J Cardiol. 2011 Sep 15;108(6):851-6. doi: 10.1016/j.amjcard.2011.04.036. Epub 2011 Jul 15.

PMID:
21762871
36.

Fatty acid desaturase 2 promoter mutation is not responsible for Δ6-desaturase deficiency.

Gregory MK, Lester SE, Cook-Johnson RJ, Gibson RA, Proudman SM, Cleland LG, James MJ.

Eur J Hum Genet. 2011 Nov;19(11):1202-4. doi: 10.1038/ejhg.2011.104. Epub 2011 Jun 1.

37.

Efficacy and mechanisms of action of vitamin D in experimental polyarthritis.

Moghaddami M, Mayrhofer G, Anderson PH, Morris HA, Van Der Hoek M, Cleland LG.

Immunol Cell Biol. 2012 Feb;90(2):168-77. doi: 10.1038/icb.2011.22. Epub 2011 Mar 29.

PMID:
21445089
38.

Fibrodysplasia ossificans progressiva presenting as ankylosing spondylitis.

Dugar M, Limaye V, Cleland LG, Ahern MJ.

Intern Med J. 2010 Dec;40(12):862-4. doi: 10.1111/j.1445-5994.2010.02363.x. No abstract available.

PMID:
21199228
39.

Measurement of hand bone mineral density in early rheumatoid arthritis using dual energy X-ray absorptiometry.

Hill CL, Schultz CG, Wu R, Chatterton BE, Cleland LG.

Int J Rheum Dis. 2010 Aug;13(3):230-4. doi: 10.1111/j.1756-185X.2010.01485.x.

PMID:
20704619
40.

Fish oil supplementation increases the cyclooxygenase inhibitory activity of paracetamol in rheumatoid arthritis patients.

Caughey GE, James MJ, Proudman SM, Cleland LG.

Complement Ther Med. 2010 Jun-Aug;18(3-4):171-4. doi: 10.1016/j.ctim.2010.05.032.

PMID:
20688263
41.

Relation between blood and atrial fatty acids in patients undergoing cardiac bypass surgery.

Metcalf RG, Cleland LG, Gibson RA, Roberts-Thomson KC, Edwards JR, Sanders P, Stuklis R, James MJ, Young GD.

Am J Clin Nutr. 2010 Mar;91(3):528-34. doi: 10.3945/ajcn.2009.28302. Epub 2010 Jan 20.

PMID:
20089730
42.

Treatment-induced stable, moderate reduction in blood cell counts correlate to disease control in early rheumatoid arthritis.

Lester SE, Proudman SM, Lee AT, Hall CA, McWilliams L, James MJ, Cleland LG.

Intern Med J. 2009 May;39(5):296-303. doi: 10.1111/j.1445-5994.2008.01737.x. Epub 2008 Jun 28.

PMID:
19371393
43.

The use of fish oil in the community: results of a population-based study.

Hill C, Gill TK, Appleton S, Cleland LG, Taylor AW, Adams RJ.

Rheumatology (Oxford). 2009 Apr;48(4):441-2. doi: 10.1093/rheumatology/ken498. Epub 2009 Jan 27. No abstract available.

PMID:
19174566
44.

Dietary omega-3 fats for treatment of inflammatory joint disease: efficacy and utility.

Proudman SM, Cleland LG, James MJ.

Rheum Dis Clin North Am. 2008 May;34(2):469-79. doi: 10.1016/j.rdc.2008.03.003.

PMID:
18638687
45.

FAT/CD36 expression alone is insufficient to enhance cellular uptake of oleate.

Eyre NS, Cleland LG, Mayrhofer G.

Biochem Biophys Res Commun. 2008 Jun 6;370(3):404-9. doi: 10.1016/j.bbrc.2008.02.164. Epub 2008 Mar 24.

PMID:
18364236
46.

Effect of dietary n-3 polyunsaturated fatty acids on the inducibility of ventricular tachycardia in patients with ischemic cardiomyopathy.

Metcalf RG, Sanders P, James MJ, Cleland LG, Young GD.

Am J Cardiol. 2008 Mar 15;101(6):758-61. doi: 10.1016/j.amjcard.2007.11.007. Epub 2008 Jan 14.

PMID:
18328835
47.

Common polymorphisms in the folate pathway predict efficacy of combination regimens containing methotrexate and sulfasalazine in early rheumatoid arthritis.

James HM, Gillis D, Hissaria P, Lester S, Somogyi AA, Cleland LG, Proudman SM.

J Rheumatol. 2008 Apr;35(4):562-71. Epub 2008 Mar 1.

PMID:
18322994
48.

Recruitment of dendritic cells and macrophages during T cell-mediated synovial inflammation.

Moghaddami M, Cleland LG, Radisic G, Mayrhofer G.

Arthritis Res Ther. 2007;9(6):R120.

49.

Characterization of prostaglandin E2 generation through the cyclooxygenase (COX)-2 pathway in human neutrophils.

St-Onge M, Flamand N, Biarc J, Picard S, Bouchard L, Dussault AA, Laflamme C, James MJ, Caughey GE, Cleland LG, Borgeat P, Pouliot M.

Biochim Biophys Acta. 2007 Sep;1771(9):1235-45. Epub 2007 Jun 28.

50.

Selective COX-2 inhibitors, eicosanoid synthesis and clinical outcomes: a case study of system failure.

James MJ, Cook-Johnson RJ, Cleland LG.

Lipids. 2007 Sep;42(9):779-85. Epub 2007 Jun 2. Review.

PMID:
17541796

Supplemental Content

Loading ...
Support Center